Last $89.19 USD
Change Today +1.36 / 1.55%
Volume 3.7M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
NASDAQ GM
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James J. Loughlin CPA

Independent Director, Chairman of Audit Committee and Member of Management Compensation & Development Committee, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 23 board members in 2 different organizations across 4 different industries.

See Board Relationships
71$849,681

Background*

Mr. James J. Loughlin, C.P.A. was Global Lead Partner in KPMG LLP, Short Hills, New Jersey from 1995 to September 2003. Mr. Loughlin has gained extensive experience serving multinational pharmaceutical manufacturing and distribution companies. He has an extensive background in accounting and financial reporting. He served in various executive positions throughout KPMG, including Managing Partner of Milwaukee, Wisconsin office, Partner-in-Charge of Human Resources for ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

2004-2009
Former Director, Chairman of the Audit Committee and Member of the Compensation Committee
2004-2009
Former Director, Chairman of Audit Committee and Member of Corporate Governance & Nominating Committee
2007-Present
Independent Director, Chairman of Audit Committee and Member of Management Compensation & Development Committee
2012-Present
Director and Chairman of Audit Committee

Education*

BS
Saint Peter's University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$117,500
Total Calculated Compensation$849,681
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $89.19 USD +1.36

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.